Our Broad Spectrum Hemp CBD is a very clean product.
This product has been processed to remove lipid and fats that are unnecessary in a CBD product. Most companies will only process the CBD once to save on money but still charge you and not tell you. We are honest and will always be an upfront honest company as we stand with our values of transparency. We have uploaded our test to show you who we are!
This product is taken directly in the mouth. Feed 1-2 droppers daily to help with muscle fatigue, pain, inflamation and stress.
You are more than welcome to put it on the food, but just remember that when added to food any and all CBD will start to break down and it now has to be broken down and absorbed in the body with food which will take longer for the CBD to take effect. This is why we recommed giving this orally. And besides your pup will love this because it taste like beef!
Want to know how CBD can help your pet? This is how...
Cannabidiolic Acid (CBDA)
CBDA, similar to THCA, is the main constituent in cannabis with elevated CBD levels. CBDA selectively inhibits the COX-2 enzyme, contributing to cannabis’ anti-inflammatory effects.
CBN is a mildly-psychoactive cannabinoid that is produced from the degradation of THC. There is usually very little to no CBN in a fresh plant. CBN acts as a weak agonist at both the CB1 and CB2 receptors, with greater affinity for CB2 receptors than CB1. The degradation of THC into CBN is often described as creating a sedative effect, known as a “couch lock.”
A non-psychoactive cannabinoid, CBG’s antibacterial effects can alter the overall effects of cannabis. CBG is thought to kill or slow bacterial growth, reduce inflammation (particularly in its acidic CBGA form), inhibit cell growth in tumor/cancer cells, and promote bone growth. It acts as a low-affinity antagonist at the CB1 receptor. CBG pharmacological activity at the CB2 receptor is currently unknown.
CBC is most frequently found in tropical cannabis varieties. CBC is known to relieve pain, reduce inflammation, inhibit cell growth in tumor/cancer cells, and promote bone growth. The effects of CBC appear to be mediated through non-cannabinoid receptor interactions.
THCV is a minor cannabinoid found in only some strains of cannabis. The only structural difference between THCV and THC is the presence of a propyl (3 carbon) group, rather than a pentyl (5 carbon) group, on the molecule. Though this variation may seem subtle, it causes THCV to produce very different effects than THC. These effects include a reduction in panic attacks, suppression of appetite, and the promotion of bone growth. THCV acts as an antagonist at the CB1 receptor and a partial agonist at the CB2 receptor.
Like THCV, CBDV differs from CBD only by the substitution of a pentyl (5 carbon) for a propyl (3 carbon) sidechain. Although research on CBDV is still in its initial stages, recent studies have shown promise for its use in the management of epilepsy. This is due to its action at TRPV1 receptors and modulation of gene expression. (Source: Citiva.com)